Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 38.05M | € 82.15M | € 62.55M | € 96.75M | € 115.98M |
Total Assets | € 475.06M | € 412.25M | € 348.40M | € 317.51M | € 322.95M |
Total Debt | € 93.42M | € 145.03M | € 54.94M | € 59.49M | € 69.21M |
Net Debt | € 55.36M | € 62.88M | € -7.61M | € -37.26M | € -46.77M |
Total Liabilities | € 233.60M | € 183.84M | € 129.43M | € 107.04M | € 124.45M |
Stockholders Equity | € 241.46M | € 228.41M | € 219.21M | € 210.72M | € 198.82M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |